Protective effects of NSAIDs on the development of Alzheimer disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurology

• Publication date

  2008-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.wnl.0000311269.57716.63PMID 18458226PMCID PMC2758242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

  2007cited by this paper
• Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.

  2005cited by this paper
• Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia.

  2005cited by this paper
• Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models

  2005cited by this paper
• The role of inflammation in Alzheimer's disease.

  2005cited by this paper
• Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.

  2005cited by this paper
• Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.

  2005cited by this paper
• Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action

  2004cited by this paper
• Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies.

  2004cited by this paper
• Rofecoxib

  2004cited by this paper
• Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data.

  2004cited by this paper
• NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo

  2003cited by this paper
• Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

  2003cited by this paper
• NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.

  2003cited by this paper
• Randomized pilot study of nimesulide treatment in Alzheimer’s disease

  2002cited by this paper
• Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.

  2001cited by this paper
• Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

  2001cited by this paper
• A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease

  1999cited by this paper
• Clinical trial of indomethacin in Alzheimer's disease

  1993cited by this paper
• Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

  year unknowncited by this paper

• Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.

  2026cites this paper
• HPLC/UV analysis of mulberry vinegar and its protective role in LPS-induced cognitive impairment via regulating NF-κB signaling pathway and amyloidogenesis in mice

  2025cites this paper
• Ibuprofen inhibits human sweet taste and glucose detection implicating an additional mechanism of metabolic disease risk reduction

  2025cites this paper
• Elucidating the Neuroprotective Mechanism of 5,7-Dimethoxyflavone and 5,7’,4’-Trimethoxyflavone Through In Silico Target Prediction and in Memory-Impaired Mice

  2025cites this paper
• Long‐Term Exposure to Non‐Steroidal Anti‐Inflammatory Medication in Relation to Dementia Risk

  2025cites this paper
• Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer´s Disease.

  2025cites this paper
• Water-Soluble Ginseng Oligosaccharides Prevent Scopolamine-Induced Cholinergic Dysfunction and Inflammatory Cytokine Overexpression

  2025cites this paper
• Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons

  2025cites this paper
• GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer’s Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation

  2025cites this paper
• Immune modulation to treat Alzheimer’s disease

  2025cites this paper
• The role of microbiota modulation in preventing Alzheimer’s disease- a review

  2025cites this paper
• Automated identification of older adults at risk for cognitive decline

  2025cites this paper
• Sex‐ and region‐dependent neuroinflammation in Alzheimer's disease

  2025cites this paper
• Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease

  2025cites this paper
• Exploring pyrazolidinone and pyrazolidinedione scaffolds for Alzheimer's therapy: multitarget COX-2 inhibitors with anti-amyloid β, anti-tau, antioxidant, and neuroprotective activities.

  2025cites this paper
• Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

  2025influential citation
• Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.

  2025cites this paper
• In vitro biological properties of pyridoxine and ketorolac conjugates.

  2025cites this paper
• Alzheimer’s disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles

  2025cites this paper
• Anti-inflammatory benzophenones from the barks of mango (Mangifera indica L.).

  2025cites this paper
• The role of APOE ε4 in modulating the relationship between non-genetic risk factors and dementia: a system review and meta-analysis

  2025cites this paper
• Excess Wnt in neurological disease

  2025cites this paper
• Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease

  2025cites this paper
• Synthesis and Molecular Docking Studies of New Ibuprofen Derivatives as AChE, BChE, and COX‐2 Inhibitors

  2024cites this paper
• A Comparative Study of the Stability, Transport, and Structure-Activity Relationship of Round Scad Derived Peptides with Antineuroinflammatory Ability.

  2024cites this paper
• Decoding Paradoxical Links of Cytokine Markers in Cognition: Cross talk between Physiology, Inflammaging, and Alzheimer's Disease- Related Cognitive Decline.

  2024cites this paper
• Role of Human Serum Albumin in the Prevention and Treatment of Alzheimer’s Disease

  2024cites this paper
• Exploring the pharmacokinetics and tolerability of cyclooxygenase inhibitor ampiroxicam: a phase I study on single and multiple oral doses

  2024cites this paper
• Role of Nonsteroidal Anti-Inflammatory Drugs as a Protective Factor in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Continuous theta burst stimulation ameliorates cognitive deficits in microinfarcts mice via inhibiting glial activation and promoting paravascular CSF-ISF exchange.

  2024cites this paper
• Neuroinflammation in Alzheimer disease

  2024cites this paper
• Inhibitory Effects of Aspirin and Ibuprofen Overdose on Cholinesterase Activity: In Vivo and In Vitro Studies.

  2024cites this paper
• Estimating the therapeutic potential of NSAIDs and linoleic acid-isomers supplementation against neuroinflammation.

  2024cites this paper
• In Search for Low-Molecular-Weight Ligands of Human Serum Albumin That Affect Its Affinity for Monomeric Amyloid β Peptide

  2024cites this paper
• Tau-targeting therapies for Alzheimer disease: current status and future directions

  2023cites this paper
• Integrating serum pharmacochemistry and network pharmacology to reveal the active constituents and mechanism of Corydalis Rhizoma in treating Alzheimer’s disease

  2023cites this paper
• A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals' models with mild cognitive impairment or dementia.

  2023cites this paper
• White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review

  2023cites this paper
• Peripheral inflammation is a potential etiological factor in Alzheimer’s disease

  2023cites this paper
• Neuroplasticity: The Critical Issue for Alzheimer's Disease and Links to Obesity and Depression.

  2023cites this paper
• Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease

  2023cites this paper
• Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury

  2023cites this paper
• A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders

  2023cites this paper
• SARM1 Promotes Neurodegeneration and Memory Impairment in Mouse Models of Alzheimer's Disease

  2023cites this paper
• Homocysteine May Decrease Glucose Uptake and Alter the Akt/GSK3β/GLUT1 Signaling Pathway in Hippocampal Slices: Neuroprotective Effects of Rivastigmine and Ibuprofen

  2023cites this paper
• Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression.

  2023cites this paper
• A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects

  2023influential citation
• Hydralazine inhibits neuroinflammation and oxidative stress in APP/PS1 mice via TLR4/NF-κB and Nrf2 pathways.

  2023cites this paper
• Thrombin, a Key Driver of Pathological Inflammation in the Brain

  2023cites this paper
• The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function

  2023cites this paper
• Non-Steroidal Anti-Inflammatory Drugs as Protective Factor in Alzheimer’s Diseases: A Systematic Review and Meta-Analysis Protocol

  2023cites this paper
• The role of human serum albumin in prevention and treatment of Alzheimer’s disease

  2023cites this paper
• Pleiotropic Potential of Evernia prunastri Extracts and Their Main Compounds Evernic Acid and Atranorin: In Vitro and In Silico Studies

  2023cites this paper
• Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation

  2023cites this paper
• New insight on microglia activation in neurodegenerative diseases and therapeutics

  2023cites this paper
• Andrographolide derivative Andro-III modulates neuroinflammation and attenuates neuropathological changes of Alzheimer's disease via GSK-3β/NF-κB/CREB pathway.

  2023cites this paper
• Adenosine receptor signalling in Alzheimer’s disease

  2022cites this paper
• Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer’s disease

  2022cites this paper
• Regulation of the Human IL-10RB Gene Expression by Sp8 and Sp9

  2022cites this paper
• ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer’s disease

  2022cites this paper
• Clausena Harmandiana Root Extract Improved Amyloid-β Induced Cognitive Impairments in Rats By Reducing Aβ1-42 Protein Levels and Neuroin ammation

  2022cites this paper
• Independent APOE4 knock‐in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines

  2022cites this paper
• Ibuprofen Favors Binding of Amyloid-β Peptide to Its Depot, Serum Albumin

  2022cites this paper
• Clausena Harmandiana root extract attenuated cognitive impairments via reducing amyloid accumulation and neuroinflammation in Aβ1-42-induced rats

  2022cites this paper
• Neuroimmune contributions to Alzheimer’s disease: a focus on human data

  2022cites this paper
• Neuroinflammation and oxidative stress in Alzheimer's disease; Can nutraceuticals and functional foods come to the rescue?

  2022cites this paper
• Mesenchymal Stem Cells Improve Cognitive Impairment and Reduce Aβ Deposition via Promoting AQP4 Polarity and Relieving Neuroinflammation in Rats With Chronic Hypertension-Induced Cerebral Small-Vessel Disease

  2022influential citation
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Bioinformatic search and formation of a panel of serum albumin ligands that modulate its interaction with Aβ-peptide

  2022cites this paper
• Systematic search for peptide and protein ligands of human serum albumin capable of affecting its interaction with amyloid β peptide

  2022cites this paper
• Evaluation of Single-Nucleotide Polymorphisms in Human Serum Albumin Associated with Alzheimer's Disease

  2022cites this paper
• Synthesis and Preclinical Evaluation of 18F-Labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation

  2022cites this paper
• ISSN: 2595-6825

  2022cites this paper
• Analgesics in neurology, their specific fealures and adverse effects

  2022cites this paper
• Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

  2022cites this paper
• Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer’s model

  2022cites this paper
• Resolvin D1: A key endogenous inhibitor of neuroinflammation

  2022influential citation
• Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK/NF-κB and glutamatergic pathways.

  2022cites this paper
• Fighting fire with fire: the immune system might be key in our fight against Alzheimer's disease.

  2022cites this paper
• Ontogenetic Principles of Accelerated Aging and the Prospects for Its Prevention and Treatment

  2022cites this paper
• Prostaglandin D2 pathway in a transgenic rat model of Alzheimer’s disease: therapeutic potential of timapiprant a DP2 antagonist

  2022cites this paper
• BACE1: More than just a β‐secretase

  2022cites this paper
• Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury

  2022cites this paper
• The Impact of Ageing on the CNS Immune Response in Alzheimer’s Disease

  2021cites this paper
• Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review

  2021cites this paper
• A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice

  2021cites this paper
• Polysaccharide from Ganoderma lucidum ameliorates cognitive impairment by regulating the inflammation of the brain-liver axis in rats.

  2021cites this paper
• Selective Disruption Of Tlr2-Myd88 Interaction Inhibits Inflammation And Attenuates Alzheimer'S Pathology

  2021cites this paper
• Indomethacin Disrupts the Formation of β-Amyloid Plaques via an α2-Macroglobulin-Activating lrp1-Dependent Mechanism

  2021cites this paper
• EK100 and Antrodin C Improve Brain Amyloid Pathology in APP/PS1 Transgenic Mice by Promoting Microglial and Perivascular Clearance Pathways

  2021cites this paper
• REVIEW ON EVALUATING THE ROLE OF NSAIDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

  2021cites this paper
• A Systematic, Knowledge Space-Based Proposal on Quality by Design-Driven Polymeric Micelle Development

  2021cites this paper
• Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme

  2021cites this paper
• N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

  2021cites this paper
• Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease

  2021cites this paper
• Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models

  2021cites this paper
• Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases

  2021cites this paper
• Aging, Dementia, and Alzheimer Disease

  2021cites this paper
• Fenamates as Potential Therapeutics for Neurodegenerative Disorders

  2021cites this paper
• Improved L-Type Amino Acid Transporter 1 (LAT1)-Mediated Delivery of Anti-Inflammatory Drugs into Astrocytes and Microglia with Reduced Prostaglandin Production.

  2021cites this paper